PHOTOCURE ANNOUNCES PAYMENT RECEIVED FOR LUMACAN® DEVELOPMENT

[at noodls] – Oslo, Norway, January 2, 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today that it has received a payment … more

View todays social media effects on SLXP

View the latest stocks trending across Twitter. Click to view dashboard

See who Salix is hiring next, click here to view